Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Meyerson

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
ESMO Gastrointestinal Oncology|February 6, 2026
Characterization of tumor-associated microbiome in multifocal small intestinal neuroendocrine tumors (SI-NETs)I T Lee, A Dohlman, T Gao, et al.
Nature Genetics|June 10, 1998
Expression of TERT in early premalignant lesions and a subset of cells in normal tissuesK A Kolquist, L W Ellisen, C M Counter, et al.
Radiology|February 1, 1994
Pulmonary embolism: comparison of MR images with radionuclide and angiographic studiesW A Erdman, R M Peshock, H C Redman, et al.
The Journal of Pathology|October 22, 2008
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survivalS Perner, P L Wagner, A Soltermann, et al.
Nature Medicine|September 30, 1999
Inhibition of telomerase limits the growth of human cancer cellsW C Hahn, S A Stewart, M W Brooks, et al.
The Journal of Pediatrics|May 1, 1991
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study GroupJ C Burns, W H Mason, M P Glode, et al.
Oncogene|December 8, 2009
TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivityM-C Liang, J Ma, L Chen, et al.
Nature Biotechnology|September 6, 2000
Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arraysK Lindblad-Toh, D M Tanenbaum, M J Daly, et al.
Cell|August 22, 1997
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalizationM Meyerson, C M Counter, E N Eaton, et al.
Oncogene|April 15, 2008
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer modelsD Li, L Ambrogio, T Shimamura, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
ESMO Gastrointestinal Oncology|February 6, 2026
Characterization of tumor-associated microbiome in multifocal small intestinal neuroendocrine tumors (SI-NETs)I T Lee, A Dohlman, T Gao, et al.
Nature Genetics|June 10, 1998
Expression of TERT in early premalignant lesions and a subset of cells in normal tissuesK A Kolquist, L W Ellisen, C M Counter, et al.
Radiology|February 1, 1994
Pulmonary embolism: comparison of MR images with radionuclide and angiographic studiesW A Erdman, R M Peshock, H C Redman, et al.
The Journal of Pathology|October 22, 2008
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survivalS Perner, P L Wagner, A Soltermann, et al.
Nature Medicine|September 30, 1999
Inhibition of telomerase limits the growth of human cancer cellsW C Hahn, S A Stewart, M W Brooks, et al.
The Journal of Pediatrics|May 1, 1991
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study GroupJ C Burns, W H Mason, M P Glode, et al.
Oncogene|December 8, 2009
TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivityM-C Liang, J Ma, L Chen, et al.
Nature Biotechnology|September 6, 2000
Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arraysK Lindblad-Toh, D M Tanenbaum, M J Daly, et al.
Cell|August 22, 1997
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalizationM Meyerson, C M Counter, E N Eaton, et al.
Oncogene|April 15, 2008
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer modelsD Li, L Ambrogio, T Shimamura, et al.
Pageof 4